Gluta

Quick links to important sections

Gluta

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gluta

Property Description
Active ingredient Glutathione (GSH)
Form Injectable solution, Capsules, Tablets, Liposomal preparations
Pharmacological class Endogenous antioxidant, Detoxifying agent
General purpose Support cellular health and manage oxidative stress
Origin Endogenous tripeptide (naturally synthesized)

Gluta is a medicinal preparation whose active ingredient is Glutathione (GSH), an endogenous tripeptide that functions as the body's primary defense system against cellular damage. As a single active ingredient product, Gluta is defined by this essential molecule, which is synthesized naturally within nearly all human cells. Glutathione is critical for maintaining the body's protective balance, a role that is widely clinically recognized for supporting cellular detoxification processes.


What is Glutathione (Gluta) and Its Chemical Identity?

Glutathione is a small protein molecule chemically formed from three specific amino acids: Cysteine, Glycine, and Glutamic Acid. This specific molecular structure is critical to its role as a sulfhydryl compound, which is key to its biological function. Gluta is unique because it is an endogenous substance—a differentiating factor that distinguishes it from synthetic medicines—whose presence and balance are fundamental to life itself. The drug Gluta provides this key molecule in various dosage form(s), including an injectable solution for systemic use, as well as capsule, tablet, and specialized liposomal preparation for oral or sublingual delivery.


Classification: Why is Gluta an Endogenous Antioxidant?

Gluta is classified pharmacologically as a potent Endogenous Antioxidant and a primary Detoxifying Agent. This classification is based on its core mechanism, which is to protect cells by directly neutralizing harmful molecules known as free radicals and reactive oxygen species (ROS), thereby managing oxidative stress. By maintaining this protective balance, the compound acts as a crucial cytoprotective agent, supporting the body's innate detoxification pathways and maintaining the structural integrity and function of cells across various tissues. The substance is typically studied and utilized in contexts demanding systemic defense, such as supporting liver function or general immunomodulation, a common context for substances in this pharmacological class.

Regulatory References

  1. The importance and regulation of hepatic glutathione

What side effects are possible with Gluta?

Possible side effects and safety information

The official safety characteristics of Gluta, whose active ingredient is the endogenous tripeptide Glutathione, are classified by the System-Organ Class affected and the route of administration, as documented in government regulatory sources.

Adverse Reactions by System-Organ Class

The most frequently reported adverse reactions for oral administration fall under Gastrointestinal Disorders, including abdominal bloating, cramping, increased gas, and loose stools. For inhaled administration, official safety documents note risks associated with the Respiratory System, such as severe bronchospasm and the worsening of asthma symptoms. Reactions across all forms may include Immune System Disorders, presenting as hypersensitivity such as rash, itching, or hives.

Serious Adverse Reactions and Systemic Concerns

The regulatory profile highlights risks of serious adverse reactions, particularly in association with the use of non-approved or non-sterile injectable preparations. These documented reactions include life-threatening Anaphylactic Shock and severe Systemic Toxicity affecting major organs like the liver (hepatotoxicity), kidneys, and the nervous system (neurotoxicity). Official safety alerts cite the risk of Sepsis and severe injection site infections due to quality concerns, such as high endotoxin levels, in non-standardized products.

Population-Specific Safety Considerations

Specific regulatory safety statements exist for certain patient groups. Individuals with Asthma have an officially documented risk of exacerbation with inhaled use. For patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency, use of Gluta carries a documented risk of inducing hemolysis. Furthermore, official regulatory documents state that the safety of Gluta use during pregnancy and lactation has not been reliably established. A time-related safety pattern notes that long-term exposure has been associated with a potential reduction in circulating zinc levels, as stated in authoritative medical resources.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for this product includes a specific, mandated directive regarding suspected intake of an excessive amount. This statement is the primary source of instruction for emergency response.

Emergency Response Guidance

Overdose scope Details (Based on Regulatory Labeling)
Documented Overdose Presentations Specific clinical manifestations are not consistently documented in the reviewed regulatory labeling.
Physiological Systems Affected Not specified in the current official labeling.
Population-Specific Notes No specific population-based risk factors are detailed in the official overdose section.
Regulatory Basis Based on general safety standards for labeling as applied by governmental health authorities.

When Immediate Medical Help is Required

The regulatory standard for this product requires seeking immediate medical attention in any case of suspected overdose. The explicit official instruction found in the labeling is: In case of overdose, get medical help or contact a Poison Control Center right away.

This statement defines the required emergency action. The official overdose information does not provide specific antidote details or advanced symptomatic management procedures, instead relying on the immediate involvement of emergency medical services and poison control experts for clinical assessment and intervention.

Therapeutic Uses of Gluta

Gluta (Glutathione) is considered relevant for providing symptomatic support in clinical scenarios generally characterized by systemic imbalance and heightened physiological stress. It is applied across domains where additional symptomatic support is needed to help manage chronic symptoms and improve overall resilience. The relevance of Gluta in high-stress clinical scenarios is often associated with therapeutic support needs, such as addressing symptoms linked to chemotherapy-induced neuropathy and other forms of drug-induced toxicity.

Gluta is commonly used to provide assistance in conditions marked by compromised liver function and elevated metabolic or drug-induced toxicity, such as nonalcoholic fatty liver disease (NAFLD), as well as neurodegenerative disorders associated with chronic fatigue and cognitive impairment. This support is relevant for easing the overall symptom burden, contributing to easing the overall symptom load during symptomatic periods.

“This intervention may be part of symptomatic management when short-term assistance is needed to address symptoms that interfere with daily functioning.”

The medicine is commonly used across domains involving systemic or localized discomfort and challenges to general well-being, which may present as susceptibility to frequent infections. This support may help patients cope more steadily with symptom fluctuations and is considered relevant for supporting general well-being during symptomatic phases.

Quick Fact: Relief for Chronic Fatigue and Brain Fog The therapeutic support Gluta provides may be applied in contexts where patients experience these symptom clusters, and may assist with maintaining functional stability and supporting general well-being during symptomatic phases.

Regulatory References

  1. Study Details (NCT02311907)

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

Regulatory agencies define the eligibility for Gluta, whose active ingredient is Glutathione, primarily based on patient hypersensitivity, the route of administration, and the availability of established safety data for specific populations.

Classification Official Regulatory Status
Absolute Contraindication Individuals with a known allergy or hypersensitivity to Glutathione or any component of the specific formulation must not use the medicine.
Route-Specific Prohibition Inhaled (nebulized) forms of Gluta are officially restricted and should be avoided by patients with asthma or other reactive airway diseases due to the risk of exacerbating symptoms.
Vulnerable Populations Use during pregnancy and breastfeeding is not recommended by regulatory bodies, as there is insufficient reliable data to establish safety in these groups.
Organ Impairment Caution Safety has not been established in patients with severe hepatic (liver) or severe renal (kidney) impairment; use in these populations is generally restricted to caution and close medical monitoring.
Age Groups Use in pediatric patients (children) is generally not established in official labeling, reflecting a lack of sufficient safety and use data.

What should I know about interactions with other medicines?

Glutathione is generally considered to have a favorable interaction profile; however, patients should always inform their healthcare provider of all prescription and over-the-counter medications, as well as supplements, before starting Gluta.

Potential Drug Interactions

Gluta (glutathione) may interact with certain classes of medications, often by affecting metabolic pathways or oxidative stress levels. Close monitoring by a physician is essential if Gluta is used concurrently with the following:

  • Chemotherapy Drugs: While Gluta may help mitigate some side effects of certain chemotherapeutic agents (like cisplatin), its antioxidant properties could theoretically interfere with the effectiveness of other anti-cancer drugs that rely on oxidative mechanisms to destroy cells. Professional guidance is necessary to manage timing and dosage.
  • Antipsychotic Drugs: Concurrent use has been suggested to alter the effect of both Gluta and the antipsychotic medication.
  • Acetaminophen (Paracetamol): High doses or chronic use of Acetaminophen may deplete the body's natural glutathione stores in the liver. Gluta supplementation may be used to help support these levels, but its use should be supervised, particularly in cases of Acetaminophen overdose where N-acetylcysteine (a glutathione precursor) is the standard antidote.

Other Important Interactions

Product Interaction Summary
Nitrates/Nitroglycerin Gluta may increase the effects of medications like nitroglycerin, potentially leading to increased side effects such as headache or low blood pressure.
Alcohol & Smoking Both can significantly deplete endogenous glutathione levels and increase oxidative stress, counteracting the potential benefits of Gluta supplementation.
High-Dose Vitamin C In some specific contexts, excessive Vitamin C supplementation may potentially interfere with Gluta's efficacy; balanced doses are generally advised.

It is crucial to maintain an open dialogue with a healthcare professional regarding all treatments to ensure safe and effective use.

Mechanism of Action

Direct Molecular Scavenging and Cytoprotection

The primary mechanism involves Glutathione's ( GSH) capacity to directly neutralize Reactive Oxygen Species (ROS) and free radicals via its reactive thiol group. This fundamental non-enzymatic reduction prevents damaging chemical reactions with cellular components, thereby consequently supports the maintenance of cellular integrity across multiple tissues.


Enzyme-Dependent Detoxification Pathways

GSH acts as the essential cofactor and substrate for the Glutathione S-Transferases ( GSTs) and Glutathione Peroxidases ( GPx) enzyme systems. This role is critical for the Phase II detoxification pathway, where GSH enables the conjugation of toxic metabolites and xenobiotics. This conjugation creates water-soluble compounds, facilitating their subsequent renal and biliary elimination.


Redox Homeostasis and Functional Regulation

The effectiveness of GSH is tied to its capacity to maintain a high GSH: GSSG ratio, which defines the cell’s internal Redox Homeostasis. This balance is crucial for regulating physiological function via redox signaling, including the S-glutathionylation of key proteins. This regulatory mechanism modulates pathways that influence the overall cellular redox state, which contributes to maintaining the structural and functional integrity of the cell.

Dosage and Administration Information

Administration Scope

Category Official Administration Rule
Route of administration Primarily administered via Intravenous (IV) infusion or Intramuscular (IM) injection for systemic effect. Oral (capsules/tablets/liposomal) and Inhalation routes are also used in professional administration contexts.
Dosing schedule (as written in regulatory sources) The regimen is indication-dependent and individualized, structured around the specific approved use, such as an adjunct treatment. Dosing is determined by the administering professional.
Timing in relation to meals (if applicable) Oral forms may be instructed to be taken with a meal and water to support patient tolerance.
Preparation requirements (if applicable) Sterile injectable solution must be reconstituted and diluted using strict aseptic technique immediately prior to use.
Age-group administration rules Use in pediatric patients is not standardized and requires specialized clinical guidance. Use in older adults requires careful consideration due to potential altered pharmacokinetics.
Missed-dose rules Specific label-based instructions for a missed dose are not universally standardized; a protocol is typically defined in line with the overall treatment cycle.
Special procedural conditions Systemic IV/IM administration must be performed by a qualified healthcare professional. Injectable solutions must not be mixed with other drug products unless compatibility is confirmed.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Systemic (IV/IM) and Local/Enteral (Oral/Inhalation).
Frequency pattern Intermittent, Cyclic, or Course-based administration.
Regulatory basis Government health authorities and principles based on medical and regulatory standards.
Use-context constraints Constrained to specific adjunctive protocols and requires professional supervision for sterile forms.

Resulting Procedural Structure

Official step sequence:

  • The appropriate dosage form and route is selected based on the approved use.
  • Injectable forms are prepared via aseptic dilution by a professional.
  • The medicine is administered on an intermittent or cyclical schedule, aligning with the established treatment course.

Connection to the overall use protocol

The official administration guidelines define the conditions under which Gluta is used, requiring professional preparation and supervision for all systemic routes. This framework ensures the medicine is administered as a time-bound, indication-dependent agent within a pre-defined treatment cycle, supporting a structured approach to its clinical application.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gluta

Gluta (Glutathione) has been the subject of multiple types of scientific studies, including randomized controlled trials and systematic reviews, which have examined its potential use in various physiological contexts. The evidence summarized here is derived from official regulatory and peer-reviewed scientific sources.


Evidence for use in Liver Support and NAFLD

Research has examined Gluta in contexts of compromised liver function, including Non-Alcoholic Fatty Liver Disease (NAFLD). Studies exploring this area include small-scale Randomized Controlled Trials (RCTs) and pilot studies.

These studies explored how symptoms change over time by monitoring liver enzyme levels (like ALT and AST), which are relevant outcomes related to systemic or functional imbalance. Some trials described patterns observed related to measured differences in liver enzyme levels and fat content over the study period, typically three to six months. What remains uncertain are the long-term observations of the condition's progression.

Evidence for Symptomatic Support during Chemotherapy

Gluta was studied for use as symptomatic support in cancer patients receiving certain toxic chemotherapy agents, specifically to monitor for Chemotherapy-Induced Peripheral Neuropathy (CIPN). The research structure includes Randomized, double-blind, placebo-controlled trials.

The studies explored outcomes related to physical discomfort, focusing on the measurement of neuropathy incidence and severity. Findings were mixed across the overall research portfolio. Large-scale trials did not always confirm observations made in smaller studies, meaning evidence quality varies across studies.

Evidence Gaps and Research Uncertainty

The current research landscape has several known limitations. For all indications, sample sizes were modest in many of the key trials, and follow-up durations were limited. This means the available evidence primarily provides insight into short-term changes, and long-term effects are not fully established. Data for certain groups remain insufficient, particularly for assessing long-term durability of measured changes after treatment is completed.

Key Studies & References

  1. A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
  2. Efficacy of Drug Interventions for Chemotherapy-Induced Chronic Peripheral Neurotoxicity: A Network Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Gluta (FAQ)


Q: How long does Gluta usually take before people feel a difference?

A: Studies examining Gluta for specific indications, such as supporting liver function, have monitored changes in measurable markers or symptoms over a period that typically ranges from a few weeks up to six months. This timeframe reflects the period over which patient outcomes and changes were monitored in clinical trials.


Q: Can Gluta interact with pain relievers like ibuprofen or acetaminophen?

A: Official information notes that chronic or high-dose use of acetaminophen (paracetamol) may reduce the body's natural glutathione stores. Official guidance emphasizes disclosing all medicines to a healthcare provider.


Q: What should I do if a side effect of Gluta seems minor, but it doesn't go away?

A: Official guidance emphasizes maintaining an open dialogue with your healthcare professional to ensure safe use. If you experience a side effect that seems minor but persists or worsens, you should consult with a qualified professional.


Q: Does Gluta need to be taken at the same time every day for it to work correctly?

A: According to official administration documents, Gluta regimens are indication-dependent and often involve intermittent or cyclical schedules. The precise timing and frequency required for the medicine are individualized and determined by the professional managing the treatment course.


Q: What are the known potential interactions between Gluta and alcohol?

A: Official warnings indicate that consuming alcohol can significantly reduce your body's natural levels of glutathione. This depletion may counteract the intended effects of the medicine.


Q: Does Gluta affect blood sugar levels?

A: Research has examined the link between the body's natural glutathione status and the regulation of glucose metabolism and insulin resistance. However, this is described in research contexts, and its direct effect on blood sugar is not typically listed as a common adverse reaction in regulatory documents.


Q: Can Gluta make me feel tired or drowsy?

A: The regulatory profile includes reports of adverse effects such as dizziness or vertigo, as noted in official sources. These are the central nervous system effects documented in the official safety information.


Q: Can taking Gluta influence weight (gain or loss)?

A: Weight change is not specifically listed as one of the common or most frequently reported adverse reactions in official safety documents. However, research has examined the role of glutathione in general metabolic processes.


Q: Can Gluta affect mood or cause anxiety?

A: Studies have explored the regulatory role of glutathione and related substances in the central nervous system, including aspects related to mood and compulsion. Official guidance advises discussing any concerns about emotional or mental effects with a healthcare professional.


Q: Is Gluta considered a prescription drug or is it available over the counter?

A: The official use-context constraints, particularly for the systemic, injectable forms, require the medicine to be prepared and administered by a qualified healthcare professional. This indicates a status and context of use that requires professional supervision.


Q: Why do people sometimes call Gluta by another name?

A: The medicine Gluta contains the single active ingredient, which is the non-proprietary (generic) name Glutathione (GSH). It may be manufactured and sold under different specific proprietary brand names depending on the region and manufacturer.


Q: Can Gluta cause long-term side effects that I need to worry about?

A: Official safety warnings note that long-term exposure to Gluta has been associated with a potential reduction in circulating zinc levels, according to authoritative medical resources. This is a potential concern noted in the long-term safety literature.


Q: What happens if I accidentally miss taking Gluta one day?

A: Specific instructions for managing a single missed dose are generally not standardized across all regulatory labels. Instead, the protocol is typically defined in line with the overall, individualized treatment cycle established by your professional.


Q: Is Gluta safe to use if I also take vitamins or herbal supplements?

A: Official guidance emphasizes the need to maintain an open dialogue with your healthcare professional regarding all treatments. This includes all vitamins, herbal supplements, and over-the-counter products, which aligns with guidance to ensure informed use and manage potential interactions.


Q: Can taking Gluta affect my sleep patterns?

A: Studies have explored the relationship between sleep deprivation and the body's natural levels of glutathione. Official guidance advises that any changes to your sleep patterns be noted and discussed with a healthcare professional.


Q: Is Gluta suitable for use in older adults (seniors)?

A: Official administration guidance notes that use in older adults requires careful consideration by a healthcare provider. This caution is due to the potential for altered pharmacokinetics (how the body handles the medicine) in this age group.


Q: Can Gluta interact with blood pressure medication?

A: Official warnings list potential interactions, noting that Gluta may affect the action of medications like nitrates, such as nitroglycerin (often used for heart or blood pressure conditions).


Q: Why is Gluta sometimes described as a 'novel' treatment?

A: Gluta’s active ingredient is Glutathione, which is an endogenous tripeptide—a key molecule naturally synthesized within nearly all human cells. This fundamental, natural identity distinguishes it chemically from many synthetic medicines.


Q: Do children or teenagers ever use Gluta, and is it approved for them?

A: Official labeling states that use in pediatric patients (children) is generally not established due to a lack of sufficient safety data. Administration in this group requires specialized clinical guidance from a qualified professional.


Q: What is the risk of a serious allergic reaction to Gluta?

A: The regulatory profile highlights risks of serious adverse reactions, including anaphylactic shock and systemic hypersensitivity. These risks are cited particularly in association with the use of non-approved or non-sterile injectable preparations.


Q: Are there different forms of Gluta available (e.g., tablet, liquid)?

A: Gluta is available in various dosage forms. These include a sterile injectable solution (IV/IM), as well as capsules, tablets, and specialized liposomal preparations for oral use.


Q: Why are there warnings about Gluta interactions with certain other medicines?

A: Warnings exist because Gluta may interact with certain classes of medications, often by affecting metabolic pathways or influencing oxidative stress levels in the body.


Q: Does Gluta have an official safety classification from a major regulatory body?

A: Official safety characteristics are classified by the System-Organ Class affected (e.g., Gastrointestinal Disorders) and the route of administration, as documented in government regulatory sources.


Q: What is the purpose of the research studies on Gluta's long-term use?

A: The research focuses on addressing existing evidence gaps, such as the limited follow-up durations in key trials. The purpose is to establish the full range of effects and long-term safety profile, which are not yet completely known.


Q: Is Gluta an anti-inflammatory medicine?

A: Gluta is classified pharmacologically as a potent endogenous antioxidant and a primary detoxifying agent. This classification is based on its core mechanism of managing cellular oxidative stress, not direct anti-inflammatory action.


Q: What are the eligibility criteria for Gluta use described in official documents?

A: Eligibility is primarily defined by Gluta's approved indications, such as specific adjunctive protocols, and by the lack of contraindications like known hypersensitivity. The decision to use it is made by a healthcare professional.


Q: Does Gluta require any special monitoring by a healthcare provider?

A: Systemic (IV/IM) forms of Gluta are required to be performed and supervised by a qualified healthcare professional. Additionally, the dosage regimen is individualized and determined by that professional.


Q: What does Gluta's official package insert say about driving or operating machinery?

A: The regulatory profile includes reports of adverse effects such as dizziness or vertigo. These effects could be relevant to the ability to drive or operate machinery, as noted in official sources.


Q: Are there any specific lifestyle changes that official guidance mentions while using Gluta?

A: Yes, official guidance notes that alcohol and smoking can deplete glutathione levels, potentially counteracting the effects of the medicine. Additionally, oral forms may be instructed to be taken with a meal.


Q: Why is the mechanism of action of Gluta sometimes complicated to explain?

A: The mechanism is often explained through three fundamental roles: direct neutralization of free radicals, acting as a cofactor for enzyme systems, and maintaining cellular redox homeostasis (the balance of protective molecules in the cell).


Q: What is the difference between the active ingredient and the inactive ingredients in Gluta?

A: The active ingredient is the substance that is intended to produce the medicinal effect, which is Glutathione (GSH). The inactive ingredients are the non-drug components of the specific formulation, such as fillers, colors, or preservatives.

How should Gluta be stored and disposed of?

Storage Conditions and Requirements

Official regulatory labeling dictates specific conditions for storing Gluta (Glutathione) to maintain its stability. The unopened product, such as the powder for injection, must be stored below 30°C and must be protected from light. Storage must occur in tight, light-resistant containers.

After reconstitution (mixing), the prepared solution has a limited shelf-life; its satisfactory potency is maintained for up to 3 hours when stored at room temperature (up to 25°C). Like all medicines, Gluta must be stored in a secure location that will Keep out of reach of children.

Disposal Instructions

Disposal of any unused or expired product must be done in accordance with federal and local laws and regulations. The product should not be released into the environment or flushed down drains. Federal guidelines recommend mixing unused medicine with an undesirable substance before sealing it in a container and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gluta found in:

A-Z Index: